期刊文献+

表皮生长因子受体、血管内皮生长因子和孕激素受体在乳腺癌患者乳腺组织的表达 被引量:4

下载PDF
导出
摘要 目的探讨孕激素受体(PR)、表皮生长因子受体(EGFR)和血管内皮生长因子(VEGF)在乳腺癌表达的意义和相关性。方法采用SP免疫组织化学技术,检测40例乳腺腺瘤和88例乳腺癌中PR、EGFR和VEGF阳性率。结果 PR,EGFR和VEGF在乳腺腺瘤中的阳性率分别为5%,20%和37.5%,EGFR在乳腺癌中阳性率为57.95(51/88);VEGF阳性率为60.22%(53/88);PR阳性率为48.86%(43/88)。在浸润性乳癌和有转移组EGFR和VEGF阳性率均高于非浸润组和无转移组(P<0.05)。PR与EGFR相关系数为0.11,PR与VEGF相关系数0.045,EGFR和VEGF相关系数为0.52。结论 EGFR和VEGF过表达与乳腺癌发生和转移呈显著正相关。PR与EGFR和VEGF呈低度正相关,检测PR、EGFR和VEGF将对乳癌靶向治疗有指导作用。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2010年第20期2911-2912,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献8

二级参考文献51

  • 1修霞,吕志民.泛素介导的表皮生长因子受体的降解[J].中国医学科学院学报,2005,27(1):120-127. 被引量:2
  • 2于晓棠,陆世伦,朱世能.表皮生长因子受体与肿瘤[J].复旦学报(医学版),2005,32(4):497-500. 被引量:20
  • 3任晓岚,汪鑫,李志裕,尤启冬.表皮生长因子受体(EGFR)酪氨酸激酶抑制剂的研究进展[J].中国新药杂志,2005,14(7):821-826. 被引量:31
  • 4陈星,任虹平,伊铁忠,糜若然,瞿全新,郑曙民,郗颜凤,连进,连争.VEGF-C MMP9及TIMP-1在宫颈癌组织中的表达及临床意义[J].中国肿瘤临床,2007,34(7):381-384. 被引量:9
  • 5Akagl K, Lkeda Y, Miyazaki M, et al. Vascular endothelial growth factor - c (VEGF-C) expression in human colorectal cancer tissues [ J ].Br J Cancer,2000,83 (7) : 887.
  • 6Ferrara N, Henzel WJ. Pituitary follicular cells secertea a novel heparin-binding growth factor specific vascular endothelial cells[J]. Biochem Biophys Res Commun, 1989,161 (2) :851.
  • 7Lim J J, Kang S, Lee MR, et al. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis [ J].J Oral Pathol Med, 2003,32 (9) ,552.
  • 8Vlachtsis K, Nikolaou A, Markou K, et al. Clinical and molecular prognostic factors in operable laryngeal cancer [ J]. Eur Arch Otorhinolaryngol, 2005,262 ( 11 ) : 890.
  • 9Shih CH, Ozawa S, Ando N, et al. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinorma of the esophagus [ J]. Clin Cancer Res ,2000,6 (3) : 1161.
  • 10Roskoski R Jr. Vascular endothelial growth factor (VEGF) signaling in tumor progression [ J]. Crit Rev Oncol Hematol, 2007,62(3) :179.

共引文献63

同被引文献42

  • 1Tanaka T, Ishiguro H, Kuwabara Y, et al. Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis[J]. J Exp Clin Cancer Res, 2010, 29(1):83.
  • 2Moriya T, Kanom ataN, Kozuk aY, et a.l Molecular morphologica lapproach to the pathological study of development andadvancement of human breast cancer[J]. Med Mol Morphol,2010,43 (2):67-73.
  • 3Nicholson S. Quantitative assays of epi- dermal growth factor receportor in human breast Caner cut-offpoints of clmcal evince [J].Int J came,2006,27( 11): 1004-1008.
  • 4Yarden Y, Sliwkowski MX. Untangling the erbB signaling network [J].Nat Rev Mol Cell Biol,2001,2(2): 127-137.
  • 5Hinestrosa MC,Dickersin K,Klein P,et al.Shapingthe future of biomarker research in breast cancer to en-sure relevance[J].Nature Reviews Cancer,2007,7:311-315.
  • 6Tavassoli FA,Devilee P.World Health Organizationclassification of tumours:pathology and genetics oftumours of the breast and female genital organs[M].Lyon:IARC Press,2003.
  • 7Burnside ES,Sickles EA,Bassett LW,et al.The ACRBI2RADS experience:learning from history[J].Journalof the American College of Radiology,2009,6(12):851-860.
  • 8Liakakos T,Xeropotamos N,Ziogas D.EGFR as aprognostic marker for gastric cancer[J].World J Surg,2008,32(6):1225-1226.
  • 9Ciardiello F,Tortora G.EGFR antagonists in cancertreatment[J].N Engl J Med,2008,358(11):1160-1174.
  • 10林建中,苏江浩,刘军,包卿兵,孙宏斌,朱佳庚.表皮生长因子受体和环氧化酶-2在前列腺癌中的共同表达和意义[J].临床泌尿外科杂志,2008,23(4):283-285. 被引量:3

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部